Acurx Pharmaceuticals Inc [NASDAQ: ACXP] stock went on an upward path that rose over 167.24% on Tuesday, amounting to a one-week price increase of more than 132.16%.
Over the last 12 months, ACXP stock dropped by -66.91%. The one-year Acurx Pharmaceuticals Inc stock forecast points to a potential upside of 83.02. The average equity rating for ACXP stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $19.27 million, with 22.40 million shares outstanding and 20.39 million shares in the current float. Compared to the average trading volume of 182.89K shares, ACXP stock reached a trading volume of 342322379 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Acurx Pharmaceuticals Inc [ACXP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ACXP shares is $4.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ACXP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Acurx Pharmaceuticals Inc is set at 0.08 The Price to Book ratio for the last quarter was 7.95, with the Price to Cash per share for the same quarter was set at 0.20.
ACXP Stock Performance Analysis:
Acurx Pharmaceuticals Inc [ACXP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 132.16. With this latest performance, ACXP shares gained by 112.07% in over the last four-week period, additionally sinking by -7.47% over the last 6 months – not to mention a drop of -66.91% in the past year of trading.
#####
Insight into Acurx Pharmaceuticals Inc Fundamentals:
Acurx Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.93 and a Current Ratio set at 1.93.
ACXP Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ACXP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Acurx Pharmaceuticals Inc go to 15.59%.
Acurx Pharmaceuticals Inc [ACXP] Institutonal Ownership Details
The top three institutional holders of ACXP stocks are: VANGUARD GROUP INC with ownership of 0.49 million shares, which is approximately 3.1071%. PROSPECT FINANCIAL SERVICES LLC, holding 0.28 million shares of the stock with an approximate value of $$0.63 million in ACXP stocks shares; and PROSPECT FINANCIAL SERVICES LLC, currently with $$0.29 million in ACXP stock with ownership which is approximately 0.8216%.
